Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
AI Meets Brain Health: League and Linus Health Collaborate to Expand Health Plan Platforms
Linus Health, a company that uses artificial intelligence to help find early signs of mental decline, has joined forces with League, a company that creates digital health platforms. This new partnership will bring digital brain health checks and tailored care options to millions of Americans through their health insurance plans. The announcement was made at the Alzheimer’s Association International Conference in Toronto, highlighting the growing focus on using technology to detect and manage cognitive health concerns more effectively.
Aptitude, BARDA Partner for $9Million on Rapid Test for Ebola and Marburg Viruses
Aptitude Medical Systems has started a new partnership with the Biomedical Advanced Research and Development Authority (BARDA), receiving $9 million in funding to develop the Metrix Filovirus Panel. This next-generation diagnostic tool is designed to rapidly detect and distinguish between Ebolavirus and Marburgvirus. The Metrix device is compact and portable, capable of delivering lab-quality results in 30 minutes or less using a small blood sample, either from a vein or a fingerstick. Its size and ease of use make it especially valuable for remote areas and clinical environments where immediate testing is needed.
AngioDynamics Enrolls First Patient in AMBITION BTK Trial for Treatment of Critical Limb Ischemia
AngioDynamics, Inc. a MedTech company focused on restoring healthy blood flow, improving cancer care, and enhancing quality of life, has enrolled the first patient in its AMBITION BTK trial. This randomized, multicenter controlled trial is evaluating the Auryon Atherectomy System used in combination with standard balloon angioplasty versus angioplasty alone for treating infrapopliteal lesions in patients diagnosed with critical limb ischemia (CLI). The study will include up to 224 patients across 30 sites, while a companion registry will track up to 1,500 patients ineligible for the main trial but treated with the Auryon system either above or below the knee.
YourBio Health Unites Scientific Leaders to Make Pain-Free Blood Collection the Standard
YourBio Health, the company behind TAP, the industry’s most advanced capillary blood collection technology, has officially launched its Scientific & Medical Advisory Board (SMAB) to accelerate its mission to modernize diagnostic testing for the 21st century.
Inmagene Biopharmaceuticals Completes Ikena Oncology Merger, Raises $75Million Private Placement
Inmagene Biopharmaceuticals, a clinical stage biotechnology company dedicated to developing disease-modifying treatments for immunological/autoimmune and inflammatory diseases, announced the completion of its previously announced merger with Ikena Oncology, Inc. The combined company will operate under the name ImageneBio and will trade on The Nasdaq Capital Market under the ticker symbol “IMA” beginning at market open on July 28, 2025.
To share your insights, please write to us at sudipto@intentamplify.com
